693 related articles for article (PubMed ID: 25284215)
1. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.
Gupta D; Radhakrishnan M; Kurhe Y
Eur J Pharmacol; 2014 Dec; 744():59-66. PubMed ID: 25284215
[TBL] [Abstract][Full Text] [Related]
2. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.
Gupta D; Radhakrishnan M; Kurhe Y
Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071
[TBL] [Abstract][Full Text] [Related]
3. A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system.
Gupta D; Thangaraj D; Radhakrishnan M
Behav Brain Res; 2016 Jan; 297():41-50. PubMed ID: 26454237
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system.
Gupta D; Kurhe Y; Radhakrishnan M
Physiol Behav; 2014 Apr; 129():73-8. PubMed ID: 24582678
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
[TBL] [Abstract][Full Text] [Related]
6. Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission.
Kurhe Y; Mahesh R
Pharmacol Biochem Behav; 2015 Sep; 136():107-16. PubMed ID: 26188166
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
[TBL] [Abstract][Full Text] [Related]
8. QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.
Kurhe Y; Radhakrishnan M; Gupta D; Devadoss T
J Pharm Pharmacol; 2014 Jan; 66(1):122-32. PubMed ID: 24180368
[TBL] [Abstract][Full Text] [Related]
9. QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.
Kurhe Y; Mahesh R; Devadoss T
Biochem Biophys Res Commun; 2015 Jan; 456(1):74-9. PubMed ID: 25446100
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
Li Y; Raaby KF; Sánchez C; Gulinello M
Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
[TBL] [Abstract][Full Text] [Related]
11. Anti-depressant effect of hesperidin in diabetic rats.
El-Marasy SA; Abdallah HM; El-Shenawy SM; El-Khatib AS; El-Shabrawy OA; Kenawy SA
Can J Physiol Pharmacol; 2014 Nov; 92(11):945-52. PubMed ID: 25358020
[TBL] [Abstract][Full Text] [Related]
12. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice.
Gupta D; Radhakrishnan M; Kurhe Y
Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of Hypericum perforatum on depression and anxiety in a type 2 diabetic rat model.
Husain GM; Chatterjee SS; Singh PN; Kumar V
Acta Pol Pharm; 2011; 68(6):913-8. PubMed ID: 22125957
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effect of simvastatin in diabetic rats.
ElBatsh MM
Can J Physiol Pharmacol; 2015 Aug; 93(8):649-56. PubMed ID: 26120891
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests.
Kurhe Y; Radhakrishnan M; Gupta D
Metab Brain Dis; 2014 Sep; 29(3):701-10. PubMed ID: 24964970
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan attenuates diabetes induced depression in rats.
Aswar U; Chepurwar S; Shintre S; Aswar M
Pharmacol Rep; 2017 Apr; 69(2):358-364. PubMed ID: 28189098
[TBL] [Abstract][Full Text] [Related]
17. The antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in the mouse forced swimming test is mediated by serotonergic and dopaminergic systems.
Pesarico AP; Sampaio TB; Stangherlin EC; Mantovani AC; Zeni G; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():179-86. PubMed ID: 24936772
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
Ramamoorthy R; Radhakrishnan M; Borah M
Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the antidepressant-like effect caused by hesperidin in mice.
Souza LC; de Gomes MG; Goes AT; Del Fabbro L; Filho CB; Boeira SP; Jesse CR
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():103-9. PubMed ID: 22996046
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system.
Gay BM; Prigol M; Stein AL; Nogueira CW
Neuropharmacology; 2010 Sep; 59(3):172-9. PubMed ID: 20488195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
